| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/12/2002 | US20020128196 Localization and characterization of the Wilms' tumor gene |
| 09/12/2002 | US20020128192 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits |
| 09/12/2002 | US20020128189 Ubiquitination of the transcription factor E2A |
| 09/12/2002 | US20020128187 Novel nucleic acids and polypeptides |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127693 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 09/12/2002 | US20020127689 Novel human galectins |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127653 Hematopoietic signaling factor |
| 09/12/2002 | US20020127648 Novel human C5a-like receptor |
| 09/12/2002 | US20020127646 CD38 modulated chemotaxis |
| 09/12/2002 | US20020127645 Secretory immunoglobulin produced by single cells and methods for making and using same |
| 09/12/2002 | US20020127644 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/12/2002 | US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics |
| 09/12/2002 | US20020127639 Nucleotide sequences coding protein for use in the treatment of diabetes, hyperlipidemia and eating disorders |
| 09/12/2002 | US20020127638 Human metabotropic glutamate receptor 7 subtypes |
| 09/12/2002 | US20020127621 KUZ, a novel family of metalloproteases |
| 09/12/2002 | US20020127616 Prenatal diagnostic methods |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127611 Detecting preferential water treatment polymer; generate antibody, incubate with water sample, monitor for the presence of preferential polymer |
| 09/12/2002 | US20020127596 murF2 |
| 09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
| 09/12/2002 | US20020127579 Breast carcinoma-associated gene |
| 09/12/2002 | US20020127578 Compositions and methods relating to prostate specific genes and proteins |
| 09/12/2002 | US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders |
| 09/12/2002 | US20020127572 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 09/12/2002 | US20020127553 Apoptin-associating protein |
| 09/12/2002 | US20020127245 Canine coronavirus S gene and uses therefor |
| 09/12/2002 | US20020127244 Fractionating a mixture of polyethylene glycol(PEG)-protein adducts comprising partitioning the PEG/protein adducts in a PEG-containing aqueous biphasic system |
| 09/12/2002 | US20020127240 Leptospiral rare outer membrane proteins |
| 09/12/2002 | US20020127239 LipL32 polypeptide is useful for inducing an immune response to a pathogenic spirochete in a patient |
| 09/12/2002 | US20020127236 Contacting the sample containing an antibody specific for isolated and purified antigenically-active blood group antigen protein or peptide to allow the formation of an immune complex; and detecting the immune complex |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127232 Activating alpha 2-macroglobulin by incubation with a nucleophilic compound to form nucleophile-activated alpha 2-macroglobulin, removing excess of nucleophilic compound, incubating activated alpha-2 macroglobulin with biomolecule |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127222 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | US20020127201 Contacting T cell with agent which binds to cytokine receptor gamma chain and stimulates an intracellular signal in T cell resulting in T cell proliferation, with proviso that agent does not consist of natural interleukin-2 |
| 09/12/2002 | US20020127200 Canine interleukin-5 proteins, canine interleukin-5 nucleic acid molecules |
| 09/12/2002 | US20020127199 Novel nucleic acids and polypeptides |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | DE10109136A1 Using inhibitor of thrombospondin-1 interaction for promoting wound healing, also for treating living skin replacements, inhibits apoptosis of wound-repair cells |
| 09/12/2002 | DE10059595A1 Proteine und den Proteinen zugrundeliegende DNA-Sequenzen mit Funktion bei Entzündungsereignissen Proteins and the proteins underlying DNA sequences function in inflammatory events |
| 09/12/2002 | CA2476611A1 Use of metabolic phenotyping in individualized treatment with amonafide |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2439986A1 Cell visual characteristic-modifying sequences |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439933A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | CA2439852A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439625A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 09/11/2002 | EP1239050A1 Method of testing remedy or preventive for hyperlipemia |
| 09/11/2002 | EP1239032A1 Lactic acid bacteria as agents for treating and preventing allergy |
| 09/11/2002 | EP1238986A2 Use of Vascular endothelial cell growth factor antagonists |
| 09/11/2002 | EP1238985A1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 09/11/2002 | EP1238282A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238279A1 Helicobacter pylori antigens in blood |
| 09/11/2002 | EP1238087A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 09/11/2002 | EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238075A2 Chordin-like molecules and uses thereof |
| 09/11/2002 | EP1238073A2 A eag gene encoding for a potassium channel |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238064A2 Srik a novel cell cycle protein associated with rip3 |
| 09/11/2002 | EP1238063A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 09/11/2002 | EP1238056A2 SEROLOGICAL DIAGNOSTIC METHOD WITH i RICKETTSIA PULICIS /i BACTERIUM |
| 09/11/2002 | EP1237930A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 09/11/2002 | EP1237929A1 Dendritic cell-specific antibodies |
| 09/11/2002 | EP1237928A1 Improvement of therapeutic potential of immunoglobulin preparations |
| 09/11/2002 | EP1237927A2 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 09/11/2002 | EP1237926A1 Human antibodies as detection reagents |
| 09/11/2002 | EP1237924A2 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 09/11/2002 | EP1237919A1 Interferon-alpha induced gene |
| 09/11/2002 | EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | EP1237912A2 Five-helix protein |
| 09/11/2002 | EP1237901A1 28 human secreted proteins |
| 09/11/2002 | EP1237900A1 Subunit optimized fusion proteins |
| 09/11/2002 | EP1237584A1 Receptor binding conjugates |
| 09/11/2002 | EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 09/11/2002 | EP1237573A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 09/11/2002 | EP1237565A1 Betaglycan as an inhibin receptor and uses thereof |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |